Danaher Co. (NYSE:DHR) Shares Bought by Janus Henderson Group PLC

Janus Henderson Group PLC grew its holdings in shares of Danaher Co. (NYSE:DHR) by 1.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,933,078 shares of the conglomerate’s stock after purchasing an additional 50,283 shares during the period. Janus Henderson Group PLC owned approximately 0.54% of Danaher worth $902,846,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Humankind Investments LLC lifted its stake in shares of Danaher by 21.5% in the 4th quarter. Humankind Investments LLC now owns 3,952 shares of the conglomerate’s stock worth $907,000 after acquiring an additional 700 shares during the period. Gotham Asset Management LLC lifted its position in Danaher by 29.0% in the fourth quarter. Gotham Asset Management LLC now owns 57,043 shares of the conglomerate’s stock worth $13,094,000 after purchasing an additional 12,828 shares during the period. Focus Partners Wealth boosted its stake in Danaher by 19.8% during the 4th quarter. Focus Partners Wealth now owns 177,596 shares of the conglomerate’s stock valued at $40,818,000 after purchasing an additional 29,409 shares in the last quarter. Full Sail Capital LLC increased its position in shares of Danaher by 2.5% during the 4th quarter. Full Sail Capital LLC now owns 2,730 shares of the conglomerate’s stock valued at $627,000 after purchasing an additional 66 shares during the period. Finally, Elefante Mark B bought a new stake in shares of Danaher in the 4th quarter worth $3,428,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Guggenheim reaffirmed a “buy” rating and set a $250.00 target price on shares of Danaher in a research note on Wednesday, April 23rd. Wells Fargo & Company lowered their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. Citigroup reissued a “buy” rating on shares of Danaher in a research note on Monday, April 7th. Stifel Nicolaus upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target on the stock in a research report on Friday, March 14th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $250.00 price objective on shares of Danaher in a research report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $264.40.

Insider Buying and Selling at Danaher

In other news, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the transaction, the executive vice president now owns 15,179 shares of the company’s stock, valued at $3,005,442. This trade represents a 51.01 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Danaher Stock Performance

Shares of NYSE DHR opened at $189.42 on Friday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. Danaher Co. has a one year low of $171.00 and a one year high of $281.70. The business’s 50-day moving average price is $198.39 and its two-hundred day moving average price is $219.21. The company has a market capitalization of $135.56 billion, a P/E ratio of 35.88, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. The firm had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. Analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.68%. Danaher’s dividend payout ratio is presently 24.85%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.